Literature DB >> 16482420

Injectable silicone biomaterial (PTQ) to treat fecal incontinence after hemorrhoidectomy.

Miranda K Y Chan1, Joe J Tjandra.   

Abstract

PURPOSE: Passive fecal incontinence after hemorrhoidectomy may occur and is socially incapacitating. There has been no effective treatment for passive fecal incontinence caused by internal anal sphincter dysfunction. This case series reviewed the outcome of therapy with injectable silicone biomaterial (PTQ) in patients who had passive fecal incontinence after hemorrhoidectomy.
METHODS: From 2003 to 2004, seven patients referred with passive fecal incontinence after hemorrhoidectomy (Milligan-Morgan hemorrhoidectomy n = 5; stapled hemorrhoidectomy n= 2) were treated with injectable PTQ implants. All were assessed with anorectal physiology testing, Wexner continence score, and objective quality of life questionnaires before and after treatment.
RESULTS: The Wexner continence score improved significantly at three months (P= 0.016) after the injectable PTQ implant and continued to improve significantly for up to 12 months (P = 0.016). The global quality of life scores (Visual Analog Scale) showed similar improvement (P = 0.016 at 3 months; P = 0.016 at 12 months). Three domains (life style, coping behavior, and depression/self-perception) of Fecal Incontinence Quality of Life Scale were significantly improved. The manometric studies showed significant improvement in maximum resting anal canal pressures (P= 0.016) after the injectable PTQ implant.
CONCLUSIONS: The injectable silicone biomaterial is an effective treatment for passive fecal incontinence after hemorrhoidectomy providing good medium-term improvement in fecal incontinence and fecal incontinence-related quality of life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482420     DOI: 10.1007/s10350-005-0307-2

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  15 in total

1.  Mesenchymal stem cells can improve anal pressures after anal sphincter injury.

Authors:  Levilester Salcedo; Maritza Mayorga; Margot Damaser; Brian Balog; Robert Butler; Marc Penn; Massarat Zutshi
Journal:  Stem Cell Res       Date:  2012-10-16       Impact factor: 2.020

Review 2.  Current status: new technologies for the treatment of patients with fecal incontinence.

Authors:  Andreas M Kaiser; Guy R Orangio; Massarat Zutshi; Suraj Alva; Tracy L Hull; Peter W Marcello; David A Margolin; Janice F Rafferty; W Donald Buie; Steven D Wexner
Journal:  Surg Endosc       Date:  2014-03-08       Impact factor: 4.584

3.  Functional outcome after anal sphincter injury and treatment with mesenchymal stem cells.

Authors:  Levilester Salcedo; Marc Penn; Margot Damaser; Brian Balog; Massarat Zutshi
Journal:  Stem Cells Transl Med       Date:  2014-05-05       Impact factor: 6.940

4.  Sacral nerve stimulation for the treatment of faecal incontinence related to dysfunction of the internal anal sphincter.

Authors:  Thomas C Dudding; David Parés; Carolynne J Vaizey; Michael A Kamm
Journal:  Int J Colorectal Dis       Date:  2010-02-02       Impact factor: 2.571

5.  Comparison of bulking agents in the treatment of fecal incontinence: a prospective randomized clinical trial.

Authors:  O J Morris; S Smith; B Draganic
Journal:  Tech Coloproctol       Date:  2013-03-23       Impact factor: 3.781

6.  Injectable synthetic calcium hydroxylapatite ceramic microspheres (Coaptite) for passive fecal incontinence.

Authors:  E Ganio; F Marino; I Giani; A Realis Luc; G Clerico; E Novelli; M Trompetto
Journal:  Tech Coloproctol       Date:  2008-06-10       Impact factor: 3.781

7.  The use of Permacol® injections for the treatment of faecal incontinence.

Authors:  Zeiad I Hussain; Michael Lim; Haider Mussa; Kazim Abbas; Stevan Stojkovic
Journal:  Updates Surg       Date:  2012-09-05

8.  Treatment of fecal incontinence - review of observational studies (OS) and randomized controlled trials (RCT) related to injection of bulking agent into peri-anal tissue.

Authors:  Felix W Leung
Journal:  J Interv Gastroenterol       Date:  2011-10-01

Review 9.  Surgical Treatment Alternatives to Sacral Neuromodulation for Fecal Incontinence: Injectables, Sphincter Repair, and Colostomy.

Authors:  Srinivas Joga Ivatury; Lauren R Wilson; Ian M Paquette
Journal:  Clin Colon Rectal Surg       Date:  2021-01-28

Review 10.  Postoperative complications after procedure for prolapsed hemorrhoids (PPH) and stapled transanal rectal resection (STARR) procedures.

Authors:  M Pescatori; G Gagliardi
Journal:  Tech Coloproctol       Date:  2008-05-30       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.